...
首页> 外文期刊>Hepato-gastroenterology. >Combined intraarterial 5-fluorouracil and intramuscular interferon-alpha therapy for advanced hepatocellular carcinoma.
【24h】

Combined intraarterial 5-fluorouracil and intramuscular interferon-alpha therapy for advanced hepatocellular carcinoma.

机译:动脉内5-氟尿嘧啶和肌内干扰素-α联合治疗晚期肝细胞癌。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We report the case of a 66-year-old man with hepatic cirrhosis and multiple hypervascular tumors in both lobes of the liver as well as tumor thrombi in the portal vein. After unresectable hepatocellular carcinoma was diagnosed, transcatheter arterial embolization was considered to be difficult, because he had major portal vein thrombosis. Conventional ultrasonically-guided local treatments, such as percutaneous ethanol injection therapy and radiofrequency ablation, were also of no value because the tumors were huge and multiple. Ultimately, he was treated with a combination of intraarterial 5-fluorouracil and intramuscular interferon-alpha. After treatment, the multiple tumors became non-enhancing on contrast computed tomography scans and showed a marked decrease in size. There were no serious adverse effects (such as myelosuppression or hepatotoxicity) during treatment or follow-up and the patient is doing well at present. In conclusion, a combination of intraarterial 5-fluorouracil with intramuscularinterferon-alpha appears to be useful for the management of advanced hepatocellular carcinoma, especially in patients for whom more aggressive treatment is not acceptable.
机译:我们报道了一个66岁的男子,患有肝硬化和肝两叶以及门静脉肿瘤血栓的多发性高血管肿瘤的病例。在诊断出无法切除的肝细胞癌后,认为经导管动脉栓塞术很困难,因为他患有严重的门静脉血栓形成。常规的超声引导局部治疗,如经皮乙醇注射疗法和射频消融,也无济于事,因为肿瘤巨大且多发。最终,他接受了动脉内5-氟尿嘧啶和肌内干扰素-α的联合治疗。治疗后,在对比计算机断层扫描中,多个肿瘤变得不增强,并显示出大小明显减少。在治疗或随访期间没有严重的不良反应(如骨髓抑制或肝毒性),患者目前状况良好。总之,动脉内5-氟尿嘧啶与肌内干扰素-α的联合治疗可用于晚期肝细胞癌的治疗,尤其是对于不能接受更积极治疗的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号